Smithies wins top award from Massry Foundation

August 29, 2002

CHAPEL HILL -- Dr. Oliver Smithies of the University of North Carolina at Chapel Hill has been selected to receive the 2002 Massry Prize for pioneering research on how genes affect health and illness in humans and other mammals. Given by the Meira and Shaul G. Massry Foundation of Beverly Hills, Calif., the award consists of a gold medal and $40,000.

Smithies will share the prize with Dr. Mario Capecchi of the University of Utah, who has done similar research. Presentation will take place Oct. 26 at the Council Chamber of the City of Beverly Hills.

Before the ceremony, at which the UNC School of Medicine faculty member will describe his work, Smithies will lecture at the University of Southern California and the University of California at Los Angeles.

Excellence professor of pathology and laboratory medicine at UNC, Smithies won the honor for gene targeting, a technique he pioneered. He and his colleagues have developed mice with mutations that model human genetic diseases such as cystic fibrosis, some forms of anemia, high blood pressure and atherosclerosis, a condition commonly called "hardening of the arteries." Thousands of other researchers around the world have adopted the technique since then.

"Information stored in DNA is remarkably similar in all living organisms," a Massry foundation citation said. "Thus, the simple house mouse has long been a surrogate for genetic studies of humans. However, initially, very few examples of mice with spontaneous, known mutations of specific genes were identified and studied. The dream of genetic scientists was to create a systematic collection of mice that had mutations in most if not every individual gene. Studying the consequences of the loss of each gene would allow scientists to deduce a gene's function, and thus to reveal its normal role in the mouse and its very likely role in humans.

"It was Oliver Smithies and Mario Capecchi, working independently, who determined how to target mutations to specific genes within cells. It was also Capecchi and Smithies who applied these techniques, called homologous recombination, to embryonic stem cells -- cells that are capable of giving rise to a whole organism. Most important, both Smithies and Capecchi also realized that homologous recombination in stem cells would allow the creation of intact mice carrying a mutation targeted to a specific gene."

Almost simultaneously, the two produced strains of mice -- one in which deletion of a specific gene closely mimicked a severe childhood neurological disease and the other in which the faulty gene was corrected.

"Their novel approach to the creation of specific mutant mice revolutionized mammalian genetics," the statement said. "It created opportunities in biomedical research never before seen in the 20th century. This elegant approach has led to development...of many thousands of useful mouse models, many of which simulate human disease states -- including cystic fibrosis, atherosclerosis, muscular dystrophy and cancer.

"The creation of these mouse models strains...forms the basis for rapid advances in diagnosis, treatment and cure of human disease. The inventive discoveries" are of "monumental importance."

Recently, along with his wife Dr. Nobuyo Madea, the UNC scientist has been studying high blood pressure -- a major human problem -- using genetically altered mice they created.

A member of the UNC Lineberger Comprehensive Cancer Center, Smithies already has earned many international, national and state awards, including the 2001 Albert Lasker Award for Basic Medical Research, often called the "America's Nobel." Other honors include two Gairdner awards, the Alfred P. Sloan Award of the General Motors Foundation, the Ciba Award of the American Heart Association, the Bristol Myers Squibb Award for cardiovascular and metabolic disease research, a North Carolina Award in Science and the International Okamoto Award from the Japan Vascular Disease Research Foundation, one of Japan's highest honors.

In a 1995 profile, the New York Times called him "a scientific phenomenon, a man whose intellectual pace has continued unabated for half a century...who continues to break new scientific ground."
Note: Smithies can be reached at (919) 966-6913. More information about him is available at

UNC News Services

University of North Carolina at Chapel Hill

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to